id: NEW:surgical_treatment_approach_mastectomy_vs_bcs_to_NEW:five_year_overall_survival_breast_cancer
name: Surgical Treatment Approach (Mastectomy vs Breast-Conserving Surgery) â†’ Five-Year Overall Survival
  in Breast Cancer
from_node:
  node_id: NEW:surgical_treatment_approach_mastectomy_vs_bcs
  node_name: Surgical Treatment Approach (Mastectomy vs Breast-Conserving Surgery)
to_node:
  node_id: NEW:five_year_overall_survival_breast_cancer
  node_name: Five-Year Overall Survival in Breast Cancer
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Locally advanced breast cancer patients receive neoadjuvant chemotherapy to shrink tumors before
  surgery'
- 'Step 2: Mastectomy provides more complete removal of breast tissue and potentially residual microscopic
  disease compared to breast-conserving surgery'
- 'Step 3: More extensive surgical resection may reduce local recurrence risk and eliminate residual cancer
  cells'
- 'Step 4: Reduced residual disease burden contributes to improved long-term survival outcomes'
evidence:
  quality_rating: A
  n_studies: 10
  primary_citation: 'Rong Qin et al. 2024. "Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy
    in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis." https://doi.org/10.1177/15330338241265030'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis pooled 10 comparative studies
  - Studies included patients from databases including PubMed and Cochrane Library through July 2023
  - Individual study citations not available in abstract
  doi: 10.1177/15330338241265030
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Meta-analysis of 10 studies (n=5018) found that mastectomy after neoadjuvant chemotherapy
  was associated with significantly higher 5-year overall survival compared to breast-conserving surgery
  (OR 2.68, 95% CI 2.19-3.28, p<0.00001) in locally advanced breast cancer patients.
quantitative_effects:
  effect_size:
    value: 2.68
    type: odds_ratio
    ci_lower: 2.19
    ci_upper: 3.28
  p_value: 1.0e-05
  sample_size: 5018
moderators:
- name: neoadjuvant_chemotherapy_response
  direction: strengthens
  strength: moderate
  description: Tumor response to neoadjuvant chemotherapy likely influences surgical outcomes and survival
    differences
- name: tumor_stage_locally_advanced
  direction: strengthens
  strength: moderate
  description: Study specifically focused on locally advanced breast cancer where surgical extent may
    be more critical
structural_competency:
  equity_implications: This mechanism relates to healthcare system decisions about treatment protocols.
    Access to appropriate surgical care and treatment decision-making may vary by healthcare system capacity,
    insurance coverage, and geographic access to specialized oncology services. Disparities in treatment
    recommendations and access could produce inequitable survival outcomes across populations.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.881449'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
